Review




Structured Review

Complement Technology Inc complement preserved normal human serum (nhs)
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Complement Preserved Normal Human Serum (Nhs), supplied by Complement Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/pooled+normal+human+serum/pmc10424147-60-0-9
Average 90 stars, based on 1 article reviews
complement preserved normal human serum (nhs) - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb"

Article Title: SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb

Journal: Blood Advances

doi: 10.1182/bloodadvances.2022009028

SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different complement pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% NHS containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Figure Legend Snippet: SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different complement pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% NHS containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.

Techniques Used: Control, Inhibition, Activation Assay, Hemolysis Assay, Incubation, Standard Deviation

Related Articles

Bacteria:

Article Title: Increased Production of Outer Membrane Vesicles by Salmonella Interferes with Complement-Mediated Innate Immune Attack
Article Snippet: .. For analyzing the sensitivity of Salmonella to serum-mediated killing, bacteria (;1 105 CFU grown in 5.8L N-minimal media (optical density at 600 nm [OD600], 0.5) were incubated with 25% normal human serum (NHS) (Astarte Biologics, Bothell, WA, USA), C3/C4-depleted human serum (Complement Technology Inc., TX, USA), or with normal mouse serum and Factor H mutant serum (40) for 1 hour at 37°C. ..

Incubation:

Article Title: Increased Production of Outer Membrane Vesicles by Salmonella Interferes with Complement-Mediated Innate Immune Attack
Article Snippet: .. For analyzing the sensitivity of Salmonella to serum-mediated killing, bacteria (;1 105 CFU grown in 5.8L N-minimal media (optical density at 600 nm [OD600], 0.5) were incubated with 25% normal human serum (NHS) (Astarte Biologics, Bothell, WA, USA), C3/C4-depleted human serum (Complement Technology Inc., TX, USA), or with normal mouse serum and Factor H mutant serum (40) for 1 hour at 37°C. ..

Mutagenesis:

Article Title: Increased Production of Outer Membrane Vesicles by Salmonella Interferes with Complement-Mediated Innate Immune Attack
Article Snippet: .. For analyzing the sensitivity of Salmonella to serum-mediated killing, bacteria (;1 105 CFU grown in 5.8L N-minimal media (optical density at 600 nm [OD600], 0.5) were incubated with 25% normal human serum (NHS) (Astarte Biologics, Bothell, WA, USA), C3/C4-depleted human serum (Complement Technology Inc., TX, USA), or with normal mouse serum and Factor H mutant serum (40) for 1 hour at 37°C. ..

other:

Article Title: An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
Article Snippet: Supplementary Methods V: Hemolysis assay Human FH-depleted serum (20 μL) (Complement technology, Inc.) was preincubated at room temperature for ten minutes with either variant FH or control FH at concentrations ranging from 25 to 600 μg/mL using gelatin-containing veronal buffer (GVB0 Complement Technology, Inc.) with 0.1 mM EDTA [GVB0.1 mM E], as the diluent.

Article Title: Human Neutrophils Respond to Complement Activation and Inhibition in Microfluidic Devices
Article Snippet: Neutrophils were pre-incubated with AVA, whereas human sera (Complement Technology, Inc., Tyler, TX, USA; product number NHS) were pre-incubated with C5 inhibitors (ECU, ECU F(ab) 2 divalent fragment following papain digestion, or RA101295) for 10 minutes at room temperature.

Article Title: Modulators of complement activity
Article Snippet: Absorbance values were normalized to a plate control of 25% (final concentration) normal human sera (#NHS; Complement Technology Inc., Tyler, Tex.) which was set to 100% hemolysis.

Article Title: A Novel Full-Length Recombinant Human Complement Factor H (CFH; GEM103) for the Treatment of Age-Related Macular Degeneration Shows Similar In Vitro Functional Activity to Native CFH.
Article Snippet: For hemolysis assays, human CFH-depleted serum and sheep erythrocytes (SEs) were obtained (Complement Technology, Inc.) and measurements performed in a SpectraMax M5e (Molecular Devices) plate reader.

Article Title: SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb
Article Snippet: Complement preserved normal human serum (NHS) was sourced from Complement Technology Inc (Tyler, TX), BioIVT (Westbury, NY), or Innovative Research (Novi, MI).

Clinical Proteomics:

Article Title: Plasmodium falciparum Gametes and Sporozoites Hijack Plasmin and Factor H To Evade Host Complement Killing.
Article Snippet: The secondary antibodies used in this study were donkey anti-goat Alexa Fluor 488 (Invitrogen), chicken anti-rabbit Alexa Fluor 647 (Invitrogen), goat anti-mouse Alexa Fluor 594 (Invitrogen), anti-goat IgGalkaline phosphatase (Millipore Sigma), anti-mouse IgG, and horseradish peroxidase (HRP)-linked antibody (Cell Signaling Technology; catalog number 7076). .. Complement factors and proteins used in this study are human serum (Complement Technology Inc.; catalog number NHS), human C3b (Complement Technology Inc.; catalog number A114), human plasminogen (Thermo Fisher Scientific; catalog number RP-43078), tissue plasminogen activator (Innovative Research; catalog number IHUTPA85SC100UG), plasminogen-depleted plasma (Affinity Biologicals; catalog number PG-DP), normal human plasma with sodium citrate as anticoagulant (Innovative Research; catalog number IPLASNAC2ML), factor H-depleted plasma (AssayPro; catalog number D700504), factor I (Complement Technology Inc.; catalog number A138), human complement factor H (Quidel; catalog number A410), plasmin from human plasma (Sigma-Aldrich; catalog number P1867), and inactivated human plasmin (Innovative Research; catalog number IHUPLMINA1MG). ..

Article Title: Plasmodium falciparum Gametes and Sporozoites Hijack Plasmin and Factor H To Evade Host Complement Killing
Article Snippet: The secondary antibodies used in this study were donkey anti-goat Alexa Fluor 488 (Invitrogen), chicken anti-rabbit Alexa Fluor 647 (Invitrogen), goat anti-mouse Alexa Fluor 594 (Invitrogen), anti-goat IgG-alkaline phosphatase (Millipore Sigma), anti-mouse IgG, and horseradish peroxidase (HRP)-linked antibody (Cell Signaling Technology; catalog number 7076). .. Complement factors and proteins used in this study are human serum (Complement Technology Inc.; catalog number NHS), human C3b (Complement Technology Inc.; catalog number A114), human plasminogen (Thermo Fisher Scientific; catalog number RP-43078), tissue plasminogen activator (Innovative Research; catalog number IHUTPA85SC100UG), plasminogen-depleted plasma (Affinity Biologicals; catalog number PG-DP), normal human plasma with sodium citrate as anticoagulant (Innovative Research; catalog number IPLASNAC2ML), factor H-depleted plasma (AssayPro; catalog number D700504), factor I (Complement Technology Inc.; catalog number A138), human complement factor H (Quidel; catalog number A410), plasmin from human plasma (Sigma-Aldrich; catalog number P1867), and inactivated human plasmin (Innovative Research; catalog number IHUPLMINA1MG). ..



Similar Products

90
CompTech Computer Technologies complement-preserved normal human serum
Complement Preserved Normal Human Serum, supplied by CompTech Computer Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/human+serum/pm38142486-106-0-10
Average 90 stars, based on 1 article reviews
complement-preserved normal human serum - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Quidel human complement preserved serum
Human Complement Preserved Serum, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/Normal+Human+Serum+-+Complement/pm36704908-45-46-51
Average 95 stars, based on 1 article reviews
human complement preserved serum - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Complement Technology Inc complement preserved normal human serum (nhs)
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Complement Preserved Normal Human Serum (Nhs), supplied by Complement Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/pooled+normal+human+serum/pmc10424147-60-0-9
Average 90 stars, based on 1 article reviews
complement preserved normal human serum (nhs) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioIVT Inc normal complement-preserved human serum
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Normal Complement Preserved Human Serum, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/normal+complement+preserved+human+serum/pmc06331245-110-9-11
Average 90 stars, based on 1 article reviews
normal complement-preserved human serum - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Asbach Medical Products GmbH pooled complement- preserved normal human serum
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Pooled Complement Preserved Normal Human Serum, supplied by Asbach Medical Products GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/pooled+complement+preserved+normal+human+serum/pm29359453-68-22-29
Average 90 stars, based on 1 article reviews
pooled complement- preserved normal human serum - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dunn Labortechnik GmbH pooled complement- preserved normal human serum
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Pooled Complement Preserved Normal Human Serum, supplied by Dunn Labortechnik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/human+pooled+plasma/pm29359453-68-25-27
Average 90 stars, based on 1 article reviews
pooled complement- preserved normal human serum - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dunn Labortechnik GmbH 2.5%, 5%, 10% or 20% pooled complement-preserved normal human serum
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
2.5%, 5%, 10% Or 20% Pooled Complement Preserved Normal Human Serum, supplied by Dunn Labortechnik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/2+5+++5+++10++or+20++pooled+complement+preserved+normal+human+serum/pmc04926246-198-16-18
Average 90 stars, based on 1 article reviews
2.5%, 5%, 10% or 20% pooled complement-preserved normal human serum - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dunn Labortechnik GmbH pooled complement-preserved normal human serum
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Pooled Complement Preserved Normal Human Serum, supplied by Dunn Labortechnik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/human+pooled+plasma/pmc04926246-198-14-18
Average 90 stars, based on 1 article reviews
pooled complement-preserved normal human serum - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Asbach Medical Products GmbH pooled complement preserved normal human serum
SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different <t>complement</t> pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% <t>NHS</t> containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.
Pooled Complement Preserved Normal Human Serum, supplied by Asbach Medical Products GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement-preserved+normal+human+serum/pooled+complement+preserved+normal+human+serum/10__1097_slash_txd__0000000000000533-82-17-24
Average 90 stars, based on 1 article reviews
pooled complement preserved normal human serum - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different complement pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% NHS containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.

Journal: Blood Advances

Article Title: SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb

doi: 10.1182/bloodadvances.2022009028

Figure Lengend Snippet: SAR443809 specifically inhibits AP without inhibiting CP or LP. SAR443809 and its corresponding IgG isotype control were tested in a series of assays to assess their ability to inhibit the different complement pathways. A dose-dilution series of SAR443809 (●) or IgG control antibody (○) were tested in the commercial Wieslab EIA assays for (A) AP, (C) CP, and (D) LP, in which the inhibition of MAC deposition upon pathway specific activation was assessed per manufacturer’s protocol. (B) Antibodies were also tested in AP hemolysis assay. Rabbit erythrocytes were incubated with 10% NHS containing Mg 2+ -EGTA in the presence of varying concentrations of either SAR443809 (●) or the isotype control (○). The extent of hemolysis was quantified using the absorbance of the released hemoglobin in the supernatant. The data reported here is a mean of 3 independent experiments ± standard deviation, for all 4 data sets.

Article Snippet: Complement preserved normal human serum (NHS) was sourced from Complement Technology Inc (Tyler, TX), BioIVT (Westbury, NY), or Innovative Research (Novi, MI).

Techniques: Control, Inhibition, Activation Assay, Hemolysis Assay, Incubation, Standard Deviation